Company / Cash per Share
Tandem Diabetes Care Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.37
FY2025
5-year range
$0.91 / $2.70
FY2021-FY2025
Trend
+29.5%
vs FY2024
Sector context
#103 of 146
Health Care
What the data says
At $1.37, Tandem Diabetes Care's cash per share ranks #103 of 146 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.89 in FY2019 to $4.41 in FY2017.
Based on SEC 10-K filings.
1.37 in FY2025 with a 5-year CAGR of -3.0%.
Improved from $0.91 to $1.37 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -20.3%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Sector benchmark
#103 of 146 in Health CareTop 71% of 146This company $1.37 Sector average $27.73
▼
-95.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 29.5% year-over-year.
- Ranks #103 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.37 | +29.5% |
| FY2024 | $1.06 | +15.7% |
| FY2023 | $0.91 | -66.2% |
| FY2022 | $2.70 | +136.7% |
| FY2021 | $1.14 | -28.3% |
| FY2020 | $1.59 | +79.1% |
| FY2019 | $0.89 | -78.5% |
| FY2018 | $4.13 | -6.2% |
| FY2017 | $4.41 | +198.3% |
| FY2016 | $1.48 | -18.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026